Kinnate Biopharma Inc.
KNTEDelisted Apr 3, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001797768
Kinnate Biopharma Inc. was delisted on Apr 3, 2024; its insiders filed their last Form 4 on Apr 5, 2024; 56 institutions reported holding it in 13F filings for Q1 2024, worth $92.2M in total; Viking Global Investors was the only superinvestor holding it.
Q2 2021 vs. Q1 2021
How the institutions holding Kinnate Biopharma Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 62 | 62 | 0 |
| Shares | 37.8M | 38.3M | +456.4K (+1.2%) |
| Value | $1.18B | $890.9M | −$286.1M (−24.3%) |
New holders (9)
Institutions that held Kinnate Biopharma Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Morgan Stanley | 87,053 | $2.03M | 0.00% |
| Renaissance Technologies LLC | 35,900 | $836.0K | 0.00% |
| HighVista Strategies LLC | 33,391 | $777.0K | 0.55% |
| Swiss National Bank | 24,000 | $559.0K | 0.00% |
| HRT Financial LP | 20,213 | $470.0K | 0.00% |
| Squarepoint Ops LLC | 13,272 | $309.0K | 0.00% |
| US Bancorp | 50 | $1.00K | 0.00% |
| Signaturefd, LLC | 59 | $1.00K | 0.00% |
| TCI Wealth Advisors, Inc. | 19 | $0 | 0.00% |
Sold out (9)
Institutions that held Kinnate Biopharma Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Farallon Capital Management, L.L.C. | 250,000 | $7.79M |
| Soleus Capital Management, L.P. | 109,000 | $3.40M |
| Parkwood LLC | 13,198 | $411.0K |
| Manufacturers Life Insurance Company, The | 7,566 | $236.0K |
| Chicago Partners Investment Group LLC | 7,620 | $204.0K |
| MetLife Investment Management | 6,421 | $200.1K |
| Metropolitan Life Insurance Co | 4,693 | $146.2K |
| Ikarian Capital, LLC | 2,000 | $62.0K |
| Bank of Montreal | 419 | $13.0K |